Masima provides automated quantitative neuroimaging analysis through its masima-RM and masima-PET technologies, delivering precise volumetric data from MRI and PET scans to enhance diagnostic accuracy for neurological disorders. The platform addresses the need for accessible, standardized, and objective imaging reports in clinical practice, improving patient outcomes and streamlining workflows for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Neurological disorders often require precise monitoring of brain structures and metabolic activity, but traditional visual inspection of MRI and PET scans can be subjective and may not detect subtle changes indicative of early-stage disease. Standardized, quantitative analysis of these scans is needed to improve diagnostic accuracy and enable earlier intervention.
Solution
Masima provides automated, quantitative neuroimaging analysis tools that deliver precise volumetric data from MRI and PET scans. The company's masima-RM and masima-PET technologies generate standardized reports with objective measurements of brain structures and metabolic activity, enhancing diagnostic accuracy for neurological disorders. By comparing individual patient data against population databases, Masima's solutions can identify subtle abnormalities imperceptible to the human eye, facilitating earlier and more accurate diagnoses. The platform aims to improve patient outcomes and streamline workflows for healthcare providers by integrating seamlessly into existing radiological evaluation processes.
Target Audience
Masima's primary customers are radiologists, neurologists, and other healthcare professionals involved in the diagnosis and monitoring of neurological disorders.
Features
- Automated brain volumetry from MRI scans using masima-RM
- Quantitative analysis of PET/CT scans with \[18F\]FDG using masima-PET
- Generation of standardized reports with easy-to-understand visualizations
- Comparison of patient data against population databases to estimate normality
- Identification of subtle changes imperceptible to visual inspection
- Secure and protected data processing compatible with LGPD, GPDR, and HIPAA
- Report delivery within three business days